Pilomotor seizures in autoimmune limbic encephalitis: description of two GAD65 antibodies- related cases and literature review

• Published in: Seizure (London, England) England), 2022-05, Vol.98, p.71-78
• Main Authors: Pondrelli, Federica, Giannoccaro, Maria Pia, Bisulli, Francesca, Ferri, Lorenzo, Menghi, Veronica, Mostacci, Barbara, Avoni, Patrizia, Liguori, Rocco, Tinuper, Paolo, Licchetta, Laura
• Format: Article
• Language: English
• Subjects: Autoimmune encephalitis; GAD65 antibodies; Ictal piloerection; Limbic encephalitis; Pilomotor seizures
• ISSN: 1059-1311; 1532-2688
• DOI: 10.1016/j.seizure.2022.03.025

•The prevalence of pilomotor seizures in patients affected by limbic encephalitis may be higher than expected.•LGI1 and GAD65 emerged as the most frequently associated antibodies to ictal piloerection.•SSR recording may help detecting ictal piloerection. Ictal piloerection (IP) is a rare manifestation of focal epilepsy. Autoimmune limbic encephalitis (LE) and malignant brain tumours are the most frequent recognized aetiologies. We selected all patients diagnosed with LE in our Institute from 2004 to 2020 and manifesting with IP. We performed a literature review on LE patients presenting IP. Of 15 patients diagnosed with LE (13.3%), two manifested IP as prominent ictal feature. One of them also had stiff-limb syndrome. Video-EEG documented ictal discharges from the right temporal regions with concomitant sympathetic skin response (SSR) recording. Antibody testing showed elevated serum and CSF titres of GAD65 antibodies (Ab), in both cases. Despite a combination of several anti-seizure medications and first- and second-line immunotherapy, they showed a poor clinical outcome after 2 and 9 years of follow-up, respectively. The literature review yielded 13 papers reporting 26 LE cases with IP. LGI1 Ab were the most frequently associated (73.1%) followed by VGKC-complex (7.7%), GAD65 (7.7%), NMDAr (3.8%), Ma2 (3.8%) and Hu (3.8%) Ab. Cases with LGI1 Ab showed a good response to immunotherapy. The prevalence of IP in our LE cohort was of 13.3%, higher than expected. According to the literature review, most cases were associated with LGI1 Ab and showed a good response to immunotherapy. With the contribution of our cases, GAD65 emerged as the second most frequently detected Ab, showing a poor outcome. Our findings widen the spectrum of IP-associated Ab, with the respective prognostic implications.